The authors would like to make a correction in the publication of the article.
The previous line “WHO has reported 24 disputed rpoB mutations, which account for 12% of RIF resistance based on surveillance data.9” has been updated to “WHO has reported 7 disputed rpoB mutations, which account for 12% of RIF resistance based on surveillance data.9
REFERENCE
- World Health Organization. Technical report on critical concentrations for drug susceptibility testing of isoniazid and the rifamycins (rifampicin, rifabutin and rifapentine). Published 5 February 2021. https://www.who.int/publications/i/item/9789240017283. Accessed 14 October 2024. Pages xiv, 39.
The authors would like to apologise for any inconvenience caused.
Declaration
The author(s) declare there are no affiliations with or involvement in any organisation or entity with any financial interest in the subject matter or materials discussed in this manuscript.
